CLIMB BIO INC. - COMM
3.5200
07-November-24 14:59:59
15 minutes delayed
Stocks
-0.1300
-3.56%
Today's range
3.4900 - 3.7850
ISIN
N/A
Source
NASDAQ
-
Climb Bio to Present at Upcoming Investor Conferences
31 Oct 2024 06:00:00 By Nasdaq GlobeNewswire
-
Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event
15 Oct 2024 06:00:00 By Nasdaq GlobeNewswire
-
11 Oct 2024 11:30:00 By Nasdaq GlobeNewswire
-
04 Oct 2024 06:00:00 By Nasdaq GlobeNewswire
-
Climb Bio to Host Virtual Investor Event on October 15, 2024
03 Oct 2024 09:00:16 By Nasdaq GlobeNewswire
-
Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc.
02 Oct 2024 08:00:23 By Nasdaq GlobeNewswire
-
Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit
11 Sep 2024 06:00:00 By Nasdaq GlobeNewswire
-
Eliem Therapeutics Announces Additions to its Leadership Team
26 Aug 2024 06:00:00 By Nasdaq GlobeNewswire
-
Eliem Therapeutics Reports Second Quarter Financial Results
14 Aug 2024 05:05:00 By Nasdaq GlobeNewswire
-
Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® Indexes
28 Jun 2024 06:00:00 By Nasdaq GlobeNewswire
-
27 Jun 2024 15:01:00 By Nasdaq GlobeNewswire
-
11 Apr 2024 06:00:00 By Nasdaq GlobeNewswire
-
Eliem Therapeutics Announces Plans to Explore Strategic Alternatives
20 Jul 2023 05:45:00 By Nasdaq GlobeNewswire
-
Eliem Therapeutics Reports First Quarter Financial Results and Business Highlights
11 May 2023 15:10:00 By Nasdaq GlobeNewswire
-
Eliem Therapeutics Reports Fourth Quarter and Year-End Financial Results and Business Highlights
06 Mar 2023 15:10:00 By Nasdaq GlobeNewswire
-
Eliem Therapeutics Provides Strategic Update and Announces Leadership Transition
09 Feb 2023 15:01:00 By Nasdaq GlobeNewswire
-
Eliem Therapeutics at the 5th Annual Evercore ISI HealthCONx Virtual Conference
30 Nov 2022 06:00:00 By Nasdaq GlobeNewswire
-
Eliem Therapeutics Reports Third Quarter Financial and Business Highlights
14 Nov 2022 05:10:00 By Nasdaq GlobeNewswire
-
Eliem Therapeutics to Participate at Two Upcoming Investor Conferences
08 Nov 2022 06:00:02 By Nasdaq GlobeNewswire
-
Eliem Therapeutics Provides Update on Pipeline Progress
05 Oct 2022 06:00:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >